Valuation: Makers Laboratories Limited

Market Cap 963M 10.13M 8.77M 8.18M 7.52M 14.2M 14.36M 96.11M 37.72M 482M 38.05M 37.21M 1.6B P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 907M 9.54M 8.26M 7.7M 7.08M 13.37M 13.52M 90.47M 35.51M 454M 35.81M 35.03M 1.5B EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
31.45%
Yield 2025 *
-
Yield 2026 -
05-26 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-10 Makers Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-07 Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-08-29 CARE Affirms BBB+ Rating on Makers Laboratories' Long-Term Bank Financing; Outlook Stable MT
25-08-08 Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-08-08 Makers Laboratories Returns to Consolidated Profit in Fiscal Q1; Shares Slide MT
25-05-26 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
24-10-29 Makers Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-08-06 Makers Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-23 Makers Laboratories Gets Board Nod to Sell Mumbai, India Property to Ipca Laboratories MT
24-05-23 Makers Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
24-05-23 Makers Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
24-02-15 Makers Laboratories Limited Announces the Resignation of Ms. Surbhi Sharma as Company Secretary / Compliance Officer, Effective March 13, 2024 CI
1 day+1.52%
1 week+5.42%
Current month+9.53%
1 month+7.79%
3 months+10.98%
6 months+29.05%
Current year+38.17%
1 week 146.2
Extreme 146.2
172
1 month 145
Extreme 145
172
Current year 112.1
Extreme 112.1
186.7
1 year 109
Extreme 109
186.7
3 years 98.05
Extreme 98.05
230
5 years 94
Extreme 94
238
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Chief Executive Officer 51 2011-08-10
Director of Finance/CFO 59 2017-10-29
Compliance Officer - 2024-05-22
Director TitleAgeSince
Director/Board Member 51 2011-08-10
Director/Board Member 52 2018-01-28
Chairman 77 2019-03-27
Change 5-day change 1-year change 3-year change Capi.($)
+1.52%+5.42%+4.98%+36.73% 9.97M
-1.22%-1.86%+18.18%+70.33% 49.54B
-1.75%+3.69%+60.31%+127.28% 40.07B
-0.08%+0.98%-3.72%+20.59% 12.4B
-0.79%+1.99%+16.92%+72.54% 11.85B
+2.11%-0.76%+31.31%+133.18% 9.1B
+1.34%+3.50%+15.77%+33.96% 6.94B
-0.26%-4.80%+39.24%-14.13% 6.88B
+1.53%+3.41%+8.87%+181.13% 6.6B
+0.79%+4.47%-31.29%+15.81% 5.63B
Average +0.31%+1.47%+16.06%+67.74% 14.9B
Weighted average by Cap. -0.67%+1.63%+26.97%+82.77%

Financials

2025 2026
Net sales 1.21B 12.7M 11M 10.25M 9.43M 17.8M 18M 120M 47.29M 604M 47.7M 46.64M 2B 1.41B 14.82M 12.83M 11.96M 11M 20.77M 21M 141M 55.17M 705M 55.64M 54.42M 2.33B
Net income 74.91M 788K 682K 636K 585K 1.1M 1.12M 7.47M 2.93M 37.48M 2.96M 2.89M 124M 23.51M 247K 214K 200K 184K 347K 351K 2.35M 921K 11.76M 929K 908K 38.96M
Net Debt 48.19M 507K 439K 409K 376K 710K 718K 4.81M 1.89M 24.11M 1.9M 1.86M 79.86M -56.5M -594K -515K -480K -441K -833K -842K -5.64M -2.21M -28.27M -2.23M -2.18M -93.62M
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
26-08-05 163.25 +1.52% 8,327
26-08-04 ₹160.80 +6.00% 52,357
26-08-03 ₹151.70 +1.78% 1,287
26-07-31 ₹149.05 -1.62% 170
26-07-30 ₹151.50 -0.53% 3,343
  1. Stock Market
  2. Stocks
  3. MAKERSL6 Stock